Profund Advisors’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-17,594
| Closed | -$377K | – | 1013 |
|
|
2023
Q2 | $377K | Buy |
17,594
+6,989
| +66% | +$150K | 0.02% | 606 |
|
|
2023
Q1 | $429K | Buy |
+10,605
| New | +$429K | 0.03% | 548 |
|
|
2018
Q4 | – | Sell |
-2,404
| Closed | -$205K | – | 1238 |
|
|
2018
Q3 | $205K | Sell |
2,404
-404
| -14% | -$34.5K | 0.01% | 1440 |
|
|
2018
Q2 | $325K | Buy |
+2,808
| New | +$325K | 0.01% | 1107 |
|